<Editors' Choice> Which is superior, the frozen elephant trunk technique alone or the classical elephant trunk technique followed by second-stage thoracic endovascular aortic repair for extensive aortic arch repair?


Journal

Nagoya journal of medical science
ISSN: 2186-3326
Titre abrégé: Nagoya J Med Sci
Pays: Japan
ID NLM: 0412011

Informations de publication

Date de publication:
Nov 2020
Historique:
entrez: 14 12 2020
pubmed: 15 12 2020
medline: 25 9 2021
Statut: ppublish

Résumé

Paraplegia is one of the most devastating complications during extensive aortic arch repair. We retrospectively analyzed our results by comparing primary repair using the frozen elephant trunk technique (FET) and the classical elephant trunk technique (CET) followed by second-stage thoracic endovascular aortic repair (TEVAR), which has been performed since 2009. Between March 1997 and September 2015, 91 patients (the mean age: 70 ± 8.6 years old, 73 men and 18 women) underwent total aortic arch replacement with either the FET (54 cases) or CET (37 cases). The CET was followed by second-stage TEVAR with a median duration of 36 days. The number of in-hospital deaths was 2 (3.7%) in FET and none in CET. The overall survival was 73% in FET and 83% in CET at 5 years with no significant difference (p=0.73). Aortic events occurred in 12 cases (22%) in FET and 3 (8%) in CET. The rate of freedom from aortic events was 77% in FET and 91% in CET at 5 years with no significant difference (p=0.45). Five neurologic events (9%) occurred after the FET, and 3 events (8%) occurred after the CET (p=0.85). No patients in the CET group experienced paraplegia, while the FET group showed a relatively high paraplegia rate (17%, p=0.014).The FET with primary repair for extensive aortic arch repair had an acceptable hospital mortality rate and aortic events but was associated with a high incidence of paraplegia. The CET followed by second-stage TEVAR achieved better early results with a low risk of paraplegia and may produce a favorable mid-term surgical outcome for extensive aortic arch repair.

Identifiants

pubmed: 33311796
doi: 10.18999/nagjms.82.4.657
pmc: PMC7719455
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

657-666

Déclaration de conflit d'intérêts

There was no conflict of interest.

Références

Ann Thorac Surg. 1995 Oct;60(4):1102-5
pubmed: 7574959
Gen Thorac Cardiovasc Surg. 2010 Oct;58(10):501-5
pubmed: 20941562
Circulation. 1996 Nov 1;94(9 Suppl):II188-93
pubmed: 8901744
Eur J Cardiothorac Surg. 2012 Dec;42(6):1018-25
pubmed: 22634630
Eur J Cardiothorac Surg. 2008 Sep;34(3):605-14; discussion 614-5
pubmed: 18555692
Gen Thorac Cardiovasc Surg. 2013 Mar;61(3):118-26
pubmed: 23054614
Eur J Cardiothorac Surg. 2015 Apr;47(4):616-20
pubmed: 24944331
Circulation. 2005 Oct 25;112(17):2619-26
pubmed: 16246961
Ann Thorac Surg. 2002 Jul;74(1):83-9
pubmed: 12118808
Ann Thorac Surg. 2012 May;93(5):1517-22
pubmed: 22443864
Eur J Cardiothorac Surg. 2010 Jun;37(6):1338-45
pubmed: 20303777
J Card Surg. 1992 Dec;7(4):301-12
pubmed: 1482823
J Thorac Cardiovasc Surg. 2009 Mar;137(3):627-34
pubmed: 19258079
Ann Thorac Surg. 2006 May;81(5):1561-9; discussion 1569
pubmed: 16631635
Ann Thorac Surg. 2002 Nov;74(5):S1821-4; discussion S1825-32
pubmed: 12440674
Ann Thorac Surg. 2007 Feb;83(2):S815-8; discussion S824-31
pubmed: 17257933
Ann Thorac Surg. 2007 Feb;83(2):S819-23; discussion S824-31
pubmed: 17257934
J Thorac Cardiovasc Surg. 2006 Feb;131(2):336-42
pubmed: 16434262
Eur J Cardiothorac Surg. 2016 Apr;49(4):1270-8
pubmed: 26385983
Gen Thorac Cardiovasc Surg. 2014 Mar;62(3):135-41
pubmed: 23943042
Vascular. 2005 Jan-Feb;13(1):5-10
pubmed: 15895668
Eur J Cardiothorac Surg. 2009 Dec;36(6):956-61
pubmed: 19589693
Ann Thorac Surg. 2005 Apr;79(4):1422-4
pubmed: 15797103
J Thorac Cardiovasc Surg. 2010 Dec;140(6 Suppl):S81-5; discussion S86-91
pubmed: 21092803
J Thorac Cardiovasc Surg. 2015 Feb;149(2):416-22
pubmed: 25439475
Thorac Cardiovasc Surg. 1983 Feb;31(1):37-40
pubmed: 6189250
Ann Thorac Surg. 2004 Jul;78(1):109-16; discussion 109-16
pubmed: 15223413
J Thorac Cardiovasc Surg. 2008 Jun;135(6):1261-9
pubmed: 18544367
J Thorac Cardiovasc Surg. 2015 May;149(5):1286-93
pubmed: 25816956
J Thorac Cardiovasc Surg. 2009 Dec;138(6):1358-62
pubmed: 19660407

Auteurs

Masato Mutsuga (M)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hiroshi Banno (H)

Department of Vascular Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yuji Narita (Y)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Kimihiro Komori (K)

Department of Vascular Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Akihiko Usui (A)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH